Come on guys, there is nothing wrong with non-holders posting comments or even being outright negative a stock... that's their opinion, nobody knows thier holding history or reasons for posting, if it's even true, and it really doesn;t matter. If a thread can't consider the claims and merit of posts against facts and releases from the company etc then it's a pretty useless thread yeah.
@LittleArt says "The feasibility study was US$1609 fob at A$/US$ 75c exchange rate. The price received so far is US$702 (presumably fob) " which is not true. The DFS quoted forecast premium zircon prices and the correlating zircon concentrate prices KMS should receive with relevant discounts for a mixed con and processing costs etc. The DFS was forecasting premium zir @ US$1950/t would translate to non-mag zir con @ US$852/t., FOB.
Bruce explained the reasons for a lower zircon con price being ~US$50 for lower TiO2 content than expected, ~US$25 lower monazite price than at DFS, and the rest (~US$75) due to a larger discount for zirc con compared to premium zircon than expected. That drop is partly offset aginst a lower AUD:USD than expected, 65c vs 75c which is means todays US$702/t = A$1080/t FOB @ 65c, vs US$852/t = A$1136/t @ 75c AUD... only a net 5% drop in price vs DFS.![]()
- Forums
- ASX - By Stock
- SFX
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-66
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SFX (ASX) to my watchlist
|
|||||
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $122.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 44820 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 3599 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44820 | 0.305 |
1 | 48000 | 0.300 |
1 | 2368 | 0.285 |
3 | 14560 | 0.280 |
1 | 50000 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 3599 | 1 |
0.330 | 16000 | 1 |
0.340 | 44830 | 2 |
0.345 | 13128 | 1 |
0.385 | 7700 | 1 |
Last trade - 07.00am 13/08/2024 (20 minute delay) ? |
Featured News
SFX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online